MedPath

The Clinical Efficiency of Tb-ERA in Chinese RIF Patients

Not Applicable
Completed
Conditions
Repeated Implantation Failure
Endometrial Receptivity
Interventions
Diagnostic Test: Endometrium biopsy
Registration Number
NCT04497558
Lead Sponsor
ShangHai Ji Ai Genetics & IVF Institute
Brief Summary

In order to further explore the clinical utility of endometrial receptivity array in patients with repeated implantation failure, the patients divide into the experimental group or the control group. In the experimental group, those patients undergo endometrial receptivity array. In the control group, those patients do not receive any treatment before next cycle of transfer. In the experimental group, according to the results of endometrial receptivity array, the transplantation time will be adjusted and retransplantation will be carried out. Statistical analysis of the two groups of primary endpoint and secondary endpoint are done.

Detailed Description

In the field of assisted reproduction techonology, there are still 10% of patients with repeated implantation failure. In order to further explore the clinical utility of endometrial receptivity array in patients with repeated implantation failure, the patients divide into the experimental group or the control group. In the experimental group, those patients undergo endometrial receptivity array. In the control group, those patients do not receive any treatment before next cycle of transfer. In the experimental group, according to the results of endometrial receptivity array, the transplantation time will be adjusted and retransplantation will be carried out. In the control group, no intervention will be performed. Statistical analysis of the two groups of primary endpoint (clinical pregnancy rate) and secondary endpoint (endometrial implantation window evaluation results, embryo implantation rate, biochemical pregnancy rate, early abortion rate, ectopic pregnancy rate) are done. Through the comparative analysis of clinical outcomes to verify the clinical efficacy of endometrial receptivity analysis in patients with repeated implant failure, this method will provide a new treatment for repeated implant failure population.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
200
Inclusion Criteria
  1. People with unexplained repeated implantation failure (3 or more times of transplantation, at least 4 or more high-quality embryos failed to conceive).
  2. Age: 20-40 years old.
  3. BMI: 19 - 24.
  4. The thickness of endometrium is more than or equal to 7 mm.
Exclusion Criteria
  1. Known causes of embryo implantation failure, such as infection, reproductive tract malformation, uterine cavity factors, immune factors, hydrosalpinx, etc.
  2. Decreased ovarian function (meet the following at least two criteria: ① 10u / L < basal follicle stimulating hormone (FSH) < 25U / L, and / or estradiol (E2) > 292.8pmol/l, and / or FSH / LH > 3; ② the number of antral follicles < 5-7 on the second to third day of menstruation; and (or) antimullerian hormone (AMH) < 0.5-1.1ng/ml.
  3. People with genetic history.
  4. Those who have done abortion and the histogenetic analysis are positive.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ERA groupEndometrium biopsyIn the experimental group, those patients undergo endometrial receptivity array. According to the results of endometrial receptivity array, the transplantation time will be adjusted and retransplantation will be carried out.
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy rate6 months

Clinical pregnancy rate in patients

Secondary Outcome Measures
NameTimeMethod
Embryo implantation rate6 months

Embryo implantation rate in patients

Biochemical pregnancy rate6 months

Biochemical pregnancy rate in patients

Ectopic pregnancy rate6 months

Ectopic pregnancy rate in patients

Endometrial implantation window evaluation results6 months

Endometrial implantation window evaluation results in tested patients

Early abortion rate6 months

Early abortion rate in patients

Trial Locations

Locations (1)

Shanghai Ji Ai Genetics & IVF Institute, Obstetrics and Gynecology Hospital of Fudan University

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath